CLINICAL_TRIALS
trial_result
· 2025-08-14
Clinical Trial Update: Long-Term PF-06651600 for the Treatment of Alopecia Areata [Phase 3]
Summary
Pfizer completed a long-term Phase 3 trial of PF-06651600 for alopecia areata. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Alopecia Areata | Phase 3 | Status: COMPLETED | Results posted: 2025-08-14